Together, these resources support patient identification, diabetes technology monitoring, population health analysis and the assessment of equity of access.
In collaboration with West Yorkshire Integrated Care Board (WYICB), CDRC has developed a comprehensive suite of reports to identify patients living with diabetes (all types) who may or may not be using specific diabetes medical-technology ((continuous glucose monitors (CGM), insulin pumps, hybrid closed loop (HCL) systems)). These reports can be used:
- To identify and prioritise the people most likely to benefit from diabetes med-tech to optimise their diabetes management at practice/PCN/sub-ICB and ICB level,
- As a population health management tool to monitor diabetes med-tech activity in line with national and local implementation plans and
- To support equity of access to diabetes med-technology.
The resource suite includes:
- Clinical reports covering continuous glucose monitoring, insulin pumps and hybrid closed-loop systems.
- Population health reports supporting analysis by diabetes type, clinical characteristics, ethnicity and deprivation.
- A supporting spreadsheet presenting report data in a more accessible and user-friendly format.
- Coding guidance supporting the accurate recording of diabetes technology within the patient record.
Accessing CDRC SystmOne Resources
To access CDRC resources within SystmOne, your organisation must be a member of the DCS Organisation Group.
For information about joining the group and accessing CDRC resources, please follow the instructions on the CDRC SystmOne Access webpage.
Clinical Reports
Locate
The reports are located in the CDRC Projects > Diabetes Technology folder:
The reports are grouped by diabetes type and technology. Further breakdowns cover clinical and demographic information, including HbA1c, test-strip prescribing, appointments, ethnicity and deprivation.
Run
To refresh the all the reports within this folder, right-click ! Diabetes Technology Folder Refresh Report and select Run.
Population Health Data Analysis
A supporting spreadsheet has been developed with acknowledgement to the Data Quality Specialists at West Yorkshire Integrated Care Board. It presents information from the Diabetes Technology reports in a more accessible format
To import the report data:
- Right-click the relevant report and select Table > Open as CSV.
- Copy columns A and B from the report output.
- Open the Diabetes Tech summary SystmOne spreadsheet.
- Paste the information into cell A1 of the Data tab.
- Review the resulting information within the Table tab
Diabetes Technology Coding
Accurate coding can support clinical care, monitoring and evaluation of access to diabetes technology.
WYICB worked with NHSE to get the following SNOMED codes added to the CT library and are included within current guidance:
- 1464561000000107 – Provision of continuous glucose monitoring system
- 1464641000000105 – Continuous glucose monitoring stopped
- 2242591000000104 – Provision of continuous subcutaneous insulin pump
- 2242611000000107 – Automated delivery of insulin using continuous subcutaneous insulin pump stopped
- 2242601000000105 – Provision of hybrid closed-loop continuous automated insulin delivery system
- 2242621000000101 – Automated delivery of insulin using hybrid closed-loop system stopped
Coding should be added only after confirming the technology currently used by the patient and reviewing the available clinical information.
National Diabetes Audit
National Diabetes Audit (NDA) 2024-25 quarterly report for England
The NDA have released their quarterly report and there is a slight difference in the methods used by the NDA and CDRC to identify patients with Type 2 Diabetes using CGM.
NDA Type 2 diabetes/Other:
- For those with type 2 diabetes, those who have any short acting insulin prescription who are recorded as on CGM over a 12 month reporting period are counted
CDRC:
- For those with type 2 diabetes, those with any insulin drug on repeat or have a current insulin pump code who are recorded as on CGM are counted.
NDA Type 1 diabetes:
- The NDA type 1 diabetes on CGM denominator is unrestricted and insulin type is not considered.
The restriction of the NDA data set for CGM coverage in the type 1 diabetes population is that is only includes CGM that has been prescribed via FP10, not other CGM types accessed most often only via specialist diabetes services in secondary care.
The new SNOMED codes above have the potential to improve coding of med-technology use in the type 1 diabetes population within a person’s SystmOne electronic clinical record.
A link to the NDA report can be found here: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/core-q4-24-25/national-diabetes-audit-nda-2024-25-quarterly-report-for-england-integrated-care-board-icb-primary-care-network-pcn-and-gp-practice
Related Diabetes Resources
Core Diabetes Resources
Access reports, alerts, templates and visualisations supporting diabetes prevention, case-finding, clinical review, medicines optimisation and ongoing management.
View the SystmOne Diabetes resources
Diabetic Kidney Disease
Access resources supporting ACR testing, albuminuria detection and coding, treatment review and ongoing management.
View the SystmOne Diabetic Kidney Disease resources
Need Help?
If you have any questions about accessing or using these resources, please contact the CDRC team: contact-cdrc@healthinnovationnenc.org.uk